Your session is about to expire
← Back to Search
Intermittent Fasting for Brain Health
N/A
Recruiting
Led By Andriy Yabluchanskiy, MD, PhD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adequate hearing and visual acuity to participate in the examinations
Age ≥55 and ≤80 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, up to 6 months
Awards & highlights
Study Summary
This trial studies if eating meals in a restricted timeframe can improve heart & brain health, potentially leading to better thinking skills.
Who is the study for?
This trial is for individuals aged between 55 and 80 who can read, write, and understand English. They should be mentally competent to consent and have a Mini-Mental State Exam score of at least 24. It's not suitable for those with major psychiatric diseases, uncontrolled substance abuse issues, certain diabetics on specific medications, or anyone with recent severe brain-related health events.Check my eligibility
What is being tested?
The study tests if sticking closely to intermittent fasting (eating within a set time frame each day) improves brain function in older adults. The focus is on whether this eating pattern enhances cognitive abilities by improving blood vessel function in the brain through certain protective pathways.See study design
What are the potential side effects?
While the trial itself does not mention specific side effects related to intermittent fasting, common ones may include hunger, fatigue, weakness during fasting periods initially until the body adapts.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can see and hear well enough to take part in exams.
Select...
I am between 55 and 80 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, up to 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, up to 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in EEG spectra
Change in neurovascular coupling using functional near infrared spectroscopy (fNIRS)
Change in neurovascular coupling using the dynamic retinal vessel analysis
Secondary outcome measures
Body composition
Change in Attention
Change in Episodic Memory
+13 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Time restricted eatingExperimental Treatment1 Intervention
not more than 10 hrs. eating window daily goal for 6 months
Find a Location
Who is running the clinical trial?
University of OklahomaLead Sponsor
455 Previous Clinical Trials
95,624 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,694 Previous Clinical Trials
28,027,293 Total Patients Enrolled
Andriy Yabluchanskiy, MD, PhDPrincipal InvestigatorUniversity of Oklahoma
4 Previous Clinical Trials
308 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger